Sovereign Pharms Drug Patent Portfolio

Sovereign Pharms owns 1 orange book drug protected by 3 US patents Given below is the list of Sovereign Pharms's drug patents along with their expiration dates.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10105324 Immediate release oral guaifenesin solution 13 Nov, 2035
Active
US9549907 Immediate release oral guaifenesin solution 13 Nov, 2035
Active
US9808431 Immediate release oral guaifenesin solution 13 Nov, 2035
Active


Given below is the list of recent legal activities going on the following drug patents of Sovereign Pharms.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 8th Year, Large Entity 10 Jul, 2024 US9549907
Entity Status Set To Undiscounted (Initial Default Setting or Status Change) 03 May, 2024 US9549907
Email Notification 03 Aug, 2022 US10105324
Change in Power of Attorney (May Include Associate POA) 03 Aug, 2022 US9808431
Email Notification 03 Aug, 2022 US9549907
Change in Power of Attorney (May Include Associate POA) 03 Aug, 2022 US9549907
Change in Power of Attorney (May Include Associate POA) 03 Aug, 2022 US10105324
Email Notification 03 Aug, 2022 US9808431
Correspondence Address Change 01 Aug, 2022 US10105324
Correspondence Address Change 01 Aug, 2022 US9549907
Correspondence Address Change 01 Aug, 2022 US9808431
Payment of Maintenance Fee, 4th Yr, Small Entity 06 Apr, 2022 US10105324
Payment of Maintenance Fee, 4th Yr, Small Entity 04 May, 2021 US9808431
Payment of Maintenance Fee, 4th Yr, Small Entity 22 Jul, 2020 US9549907
Patent Issue Date Used in PTA Calculation 23 Oct, 2018 US10105324


Sovereign Pharms's Family Patents

Sovereign Pharms drugs have patent protection in a total of 1 countries. It has a significant patent presence in the US with 100.0% of its patents being US patents. Click below to unlock the full patent family tree.

Family Patents



Sovereign Pharms Drug List

Given below is the complete list of Sovereign Pharms's drugs and the patents protecting them.


1. Obredon

Obredon is protected by 3 patents, out of which none have expired yet. Check out its patent list below.

Drug Patent Number Drug Patent Title Drug Patent Expiry Status
US10105324 Immediate release oral guaifenesin solution 13 Nov, 2035
(11 years from now)
Active
US9549907 Immediate release oral guaifenesin solution 13 Nov, 2035
(11 years from now)
Active
US9808431 Immediate release oral guaifenesin solution 13 Nov, 2035
(11 years from now)
Active

Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Obredon's drug page


Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List